Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
Background. Bedaquiline is currently a drug of choice in therapy for extensively and multidrug-resistant tuberculosis. It is indicated for children from a 6-year age and young adults as part of a combination chemotherapy, in compliance with the medical council’s (MC) regulation on active extensively...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2022-05-01
|
| Edice: | Кубанский научный медицинский вестник |
| Témata: | |
| On-line přístup: | https://ksma.elpub.ru/jour/article/view/2764 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|